Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Western Ontario

$32,000.00

Molecular Mechanism of Error-free DNA Damage Response

EF 2019-20

Résumé
***DNA-based organisms face a great challenge of maintaining genomic stability, due to DNA damage that arises constantly by cellular metabolic processes or by environmental conditions (such as UV and ionizing radiation and chemical agents). A variety of DNA damage responses have evolved to deal with DNA damage and genomic alterations; these responses include DNA repair and lesion bypass. Most lesions (damage) are repaired by DNA repair. However, some lesions are resistant to DNA repair, become blocking sites for normal DNA replication, and pose serious problems for cell survival. Lesion bypass pathways are required for cell survival.***The DNA damage tolerance process is divided into two parallel pathways: error-prone and error-free lesion bypasses. The error-free pathway bypasses DNA lesions, without increasing the mutation rates. A little knowledge exists for the error-free pathway. Homologous recombination (HR) is required for error-free lesion bypass, but the molecular events involved are not clear. ***Recently, four genes in budding yeast, CSM2, PSY3, SHU1 and SHU2, have been identified that are involved in the error-free lesion bypass. The four gene products form a stable, 4-subunit Shu complex that is required for efficient HR. Inactivation of any of these genes makes yeast cells more sensitive to DNA damage agents. The Shu complex binds both single- and double-stranded DNA and appears to recruit HR proteins to facilitate DNA strand switching. Thus, the Shu complex is a regulator of DNA recombination or exchange and important to error-free DNA lesion bypass. In addition, Shu homologs have been identified in fission yeast, C. elegans and humans, indicating a common mechanism has been conserved in eukaryotes. ***To reveal the molecular mechanism of error-free lesion bypass, we propose to conduct a structure-function study of the Shu complex. The current goals of this study are: 1) determine the biochemical functions of the Shu complex; 2) determine the structures of the Shu complex in binary (with ATP, or DNA) and ternary forms (with both ATP and DNA) forms; 3). determine the structure of the human Shu homolog SWS1-SWAP1. We will use X-ray crystallography analysis, in combination with molecular biology and biochemistry techniques, to study the tetrameric complex. The proposed studies of the Shu complex will help us to determine which Shu proteins manipulate the specificity of DNA binding and how the Shu proteins cooperate to facilitate HR and error-free DNA lesion bypass.**
Programme
Discovery Grants Program - Individual
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2019-06165
Name nom
Ling, Hong
Department département
Biochemistry
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Installment
inst:1 - 5
Partie
1
Nb partie
5
Application title
Molecular Mechanism of Error-free DNA Damage Response
Keyword
NSERC
Application summary
***DNA-based organisms face a great challenge of maintaining genomic stability, due to DNA damage that arises constantly by cellular metabolic processes or by environmental conditions (such as UV and ionizing radiation and chemical agents). A variety of DNA damage responses have evolved to deal with DNA damage and genomic alterations; these responses include DNA repair and lesion bypass. Most lesions (damage) are repaired by DNA repair. However, some lesions are resistant to DNA repair, become blocking sites for normal DNA replication, and pose serious problems for cell survival. Lesion bypass pathways are required for cell survival.***The DNA damage tolerance process is divided into two parallel pathways: error-prone and error-free lesion bypasses. The error-free pathway bypasses DNA lesions, without increasing the mutation rates. A little knowledge exists for the error-free pathway. Homologous recombination (HR) is required for error-free lesion bypass, but the molecular events involved are not clear. ***Recently, four genes in budding yeast, CSM2, PSY3, SHU1 and SHU2, have been identified that are involved in the error-free lesion bypass. The four gene products form a stable, 4-subunit Shu complex that is required for efficient HR. Inactivation of any of these genes makes yeast cells more sensitive to DNA damage agents. The Shu complex binds both single- and double-stranded DNA and appears to recruit HR proteins to facilitate DNA strand switching. Thus, the Shu complex is a regulator of DNA recombination or exchange and important to error-free DNA lesion bypass. In addition, Shu homologs have been identified in fission yeast, C. elegans and humans, indicating a common mechanism has been conserved in eukaryotes. ***To reveal the molecular mechanism of error-free lesion bypass, we propose to conduct a structure-function study of the Shu complex. The current goals of this study are: 1) determine the biochemical functions of the Shu complex; 2) determine the structures of the Shu complex in binary (with ATP, or DNA) and ternary forms (with both ATP and DNA) forms; 3). determine the structure of the human Shu homolog SWS1-SWAP1. We will use X-ray crystallography analysis, in combination with molecular biology and biochemistry techniques, to study the tetrameric complex. The proposed studies of the Shu complex will help us to determine which Shu proteins manipulate the specificity of DNA binding and how the Shu proteins cooperate to facilitate HR and error-free DNA lesion bypass.**